Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.210
+0.020 (0.63%)
Dec 27, 2024, 4:00 PM EST - Market closed
Arbutus Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 27, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 608 | 419 | 365 | 526 | 301 | 173 | |
| Market Cap Growth | 113.68% | 15.00% | -30.72% | 74.57% | 74.57% | -18.73% | |
| Enterprise Value | 484 | 285 | 189 | 556 | 353 | 239 | |
| Last Close Price | 3.21 | 2.50 | 2.33 | 3.89 | 3.55 | 2.78 | |
| PS Ratio | 85.86 | 23.11 | 9.34 | 47.89 | 43.60 | 28.73 | |
| PB Ratio | 5.69 | 3.95 | 2.66 | 3.11 | 2.96 | 2.37 | |
| P/TBV Ratio | 6.80 | 3.95 | 2.66 | 3.11 | - | - | |
| EV/Sales Ratio | 71.83 | 15.69 | 4.84 | 50.59 | 51.00 | 39.78 | |
| Debt / Equity Ratio | 0.06 | 0.08 | 0.09 | 0.11 | 0.22 | 0.31 | |
| Asset Turnover | 0.05 | 0.11 | 0.20 | 0.06 | 0.06 | 0.04 | |
| Quick Ratio | 6.85 | 5.68 | 4.51 | 13.92 | 13.06 | 11.76 | |
| Current Ratio | 7.02 | 5.87 | 4.60 | 14.32 | 13.38 | 11.99 | |
| Return on Equity (ROE) | -67.81% | -59.99% | -45.35% | -56.19% | -72.97% | -112.63% | |
| Return on Assets (ROA) | -32.83% | -28.70% | -19.76% | -26.22% | -29.51% | -25.47% | |
| Return on Capital (ROIC) | -40.40% | -36.93% | -23.40% | -28.63% | -32.60% | -28.76% | |
| Earnings Yield | -12.61% | -17.38% | -19.05% | -14.49% | -21.15% | -89.03% | |
| FCF Yield | -11.82% | -20.74% | -9.84% | -12.99% | -17.14% | -41.46% | |
| Buyback Yield / Dilution | -10.83% | -9.95% | -42.07% | -40.10% | -32.83% | -3.24% | |
| Total Shareholder Return | -10.83% | -9.95% | -42.07% | -40.10% | -32.83% | -3.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.